Eli Lilly Stock Slumps On Worries About RFK Jr.'s Weight-Loss …

Nov 22, 2024 · Eli Lilly stock hit an intraday peak at 972.53 on Aug. 22, surging almost 67% to that point. Shares of Novo Nordisk were on a similar trajectory, up 43% this year through a …

CouponFollow Extension

67%
OFF

Eli Lilly Stock Slumps On Worries About RFK Jr.'s Weight-Loss …

4 weeks from now

Nov 22, 2024 · Eli Lilly stock hit an intraday peak at 972.53 on Aug. 22, surging almost 67% to that point. Shares of Novo Nordisk were on a similar trajectory, up 43% this year through a …

investors.com

67%
OFF

RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk …

4 weeks from now

Eli Lilly stock hit an intraday peak at 972.53 on Aug. 22, surging almost 67% to that point. Shares of Novo Nordisk were on a similar trajectory, up 43% this year through a peak at 148.15 on …

msn.com

27%
OFF

Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs

4 weeks from now

Nov 21, 2024 · Eli Lilly stock struggles despite 27% gains over the past year; RFK Jr.'s HHS appointment sparks GLP-1 drug fears. Analysts see long-term growth for obesity drugs; …

benzinga.com

3%
OFF

RFK Jr. Is Not A Fan Of Weight-loss Drugs Or Vaccines. Stocks Are ...

4 weeks from now

Nov 16, 2024 · Eli Lilly's stock was down 3% Friday, and U.S.-listed shares of Novo Nordisk were down 3.5%. Shares of other companies working to develop weight-loss drugs also fell. Viking …

morningstar.com

11%
OFF

RFK Jr. Sparks New Worries About Obesity Drugs. Here’s What

4 weeks from now

Nov 20, 2024 · Eli Lilly shares are down 11% since president-elect Donald Trump nominated Robert F. Kennedy, Jr. to be Secretary of Health and Human Services.

yahoo.com

52%
OFF

Weight Loss Drugs Have Huge Upside, Market Overreacted To RFK …

4 weeks from now

Nov 20, 2024 · The analysts maintain their $156 price target for Novo Nordisk stock, implying 52% upside from current levels, as well as a price target of $1010 for Eli Lilly, a potential 38% …

businessinsider.com

$1.18
OFF

Eli Lilly Stock Crushed As Weight Loss Sales, Profits, Disappoint Wall ...

4 weeks from now

Oct 30, 2024 · Eli Lilly's bottom line of $1.18 per share was also south of Wall Street's $1.47 forecast, and the group lowered its full-year outlook to between $13.02 and $13.52 per share.

yahoo.com

$2
OFF

Eli Lilly Stock Pops As It Bolsters Weight-Loss Drugs With A Nearly …

4 weeks from now

Jul 14, 2023 · Eli Lilly stock jumped Friday after unveiling a nearly $2 billion takeover that could bolster its efforts among weight-loss drugs. The company is hoping to curb the lean muscle …

investors.com

$100
OFF

Jim Cramer On Eli Lilly (LLY) After Trump Picked RFK Jr. To Run HHS

4 weeks from now

Nov 15, 2024 · Some on Wall Street expect the market for GLP-1 drugs to be worth $100 billion by 2030. GLP-1s drugs mimic a gut hormone to help regulate blood sugar and suppress …

mchunguzi.com

FAQs about Eli Lilly Stock Slumps On Worries About RFK Jr.'s Weight-Loss … Coupon?

Did RFK Jr Spook Eli Lilly & Novo Nordisk?

RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried? Robert F. Kennedy Jr.'s potential appointment to HHS has spooked Eli Lilly stock and stocks tied to popular weight-loss drugs. The Daily Crossword was played 8,562 times last week. ...

Why are Eli Lilly shares down 11%?

RFK Jr. Sparks New Worries About Obesity Drugs. Here’s What Investors Should Focus on Instead. RFK Jr. Sparks New Worries About Obesity Drugs. Here’s What Investors Should Focus on Instead. Eli Lilly shares are down 11% since president-elect Donald Trump nominated Robert F. Kennedy, Jr. to be Secretary of Health and Human Services. ...

Did Eli Lilly make knock off weight loss drugs?

Getty Images Eli Lilly, a pharmaceutical company, filed three separate lawsuits against online vendors and a medical spa for making knock off weight loss drugs. The pharmaceutical company's popular weight loss drug, Zepbound, has an active ingredient of tirzepatide, which the copycat versions falsely claim to contain. ...

Did Eli Lilly cut its outlook?

Lilly cut its outlook and Eli Lilly stock slumped 6.3%. Similarly, Novo's semaglutide sales came up mixed. It sells semaglutide as a diabetes treatment called Ozempic and the weight-loss drug Wegovy. Wegovy sales beat third-quarter forecasts, but Ozempic came in light and Novo tightened its outlook for the year. Shares fell more than 4%. ...

What happened to Eli Lilly & Novo Nordisk?

Still, in the aftermath, Eli Lilly stock has dropped 4.8%. Novo Nordisk stock has shed 2.2%. Shares of Amgen, Pfizer and Roche have lost between 2% and 4%. Smaller biotech Structure Therapeutics has plunged more than 17% since the news Kennedy may head HHS, as of midday Thursday. ...

Will RFK handle weight-loss drugs?

Though Kennedy has yet to overtly comment on how he would handle weight-loss drugs, there are hints that he's not that impressed with the new wave of treatments. In a recent interview with Fox News, RFK Jr. suggested the best approach to treating obesity is through nutrition rather than pharmaceuticals. ...